Bribery Scandal Threatens Future of Big Pharma in China


Sep 19, 2013

China is on course to become the second-largest pharmaceutical market in the world, with sales expected to eclipse $350 billion by 2020, but recent investigations into the pharmaceutical industry are threatening the future of some of these companies in this lucrative emerging market.

Police investigations into China's pharmaceutical sector has hurt sales at international and local firms, with many doctors at Chinese hospitals refusing to see drug representatives for fear of being caught up in the widening scandal. Read more
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments